LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.24 | 17.25 | 2462 | 4929 | 0.4995 | 0.8369 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.24 | 17.25 | 609 | 4929 | 0.1236 | 0.5478 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.24 | 17.25 | 3078 | 4929 | 0.6245 | 0.8878 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 17.25 | 2485 | 4942 | 0.5028 | 0.8384 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 17.25 | 2576 | 4942 | 0.5212 | 0.8465 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 17.25 | 650 | 4942 | 0.1315 | 0.5599 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 17.25 | 3205 | 4942 | 0.6485 | 0.8966 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.18 | 17.25 | 2626 | 5031 | 0.5219 | 0.8473 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.18 | 17.25 | 2704 | 5031 | 0.5374 | 0.8539 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.18 | 17.25 | 731 | 5031 | 0.1453 | 0.5802 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.18 | 17.25 | 3353 | 5031 | 0.6664 | 0.9033 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.15 | 17.25 | 2744 | 5061 | 0.5422 | 0.8561 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.15 | 17.25 | 2810 | 5061 | 0.5552 | 0.8615 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.15 | 17.25 | 1953 | 5061 | 0.3859 | 0.7806 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.15 | 17.25 | 3464 | 5061 | 0.6844 | 0.9096 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.12 | 17.25 | 2860 | 5095 | 0.5613 | 0.8641 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.12 | 17.25 | 2924 | 5095 | 0.5739 | 0.8691 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.12 | 17.25 | 2518 | 5095 | 0.4942 | 0.8354 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.12 | 17.25 | 3615 | 5095 | 0.7095 | 0.9181 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.09 | 17.25 | 2999 | 5221 | 0.5744 | 0.8699 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.09 | 17.25 | 3048 | 5221 | 0.5838 | 0.8736 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.09 | 17.25 | 2865 | 5221 | 0.5488 | 0.8595 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.09 | 17.25 | 3728 | 5221 | 0.7140 | 0.9199 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.06 | 17.25 | 3116 | 5242 | 0.5944 | 0.8777 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.06 | 17.25 | 3173 | 5242 | 0.6052 | 0.8819 | MN20160310_N02 | C11 |